A broad look into the future of rheumatoid arthritis
Standard
A broad look into the future of rheumatoid arthritis. / Mucke, Johanna; Krusche, Martin; Burmester, Gerd R.
in: THER ADV MUSCULOSKEL, Jahrgang 14, 2022, S. 1759720X221076211.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - A broad look into the future of rheumatoid arthritis
AU - Mucke, Johanna
AU - Krusche, Martin
AU - Burmester, Gerd R
N1 - © The Author(s), 2022.
PY - 2022
Y1 - 2022
N2 - Despite all improvements in rheumatoid arthritis, we are still not able to prevent or cure the disease. Diagnostic delays due to lack of access to a specialist and costly therapies are still a major obstacle for many patients. Even in first-world countries, the treat-to-target principle and the goal of disease remission are often missed. Thus, rheumatoid arthritis (RA) is still the reason for disability and reduced quality of life for many patients. So, is it time to move the goalpost even further? Where are we heading next? And will we finally be able to cure the disease? These questions are addressed in our review article.
AB - Despite all improvements in rheumatoid arthritis, we are still not able to prevent or cure the disease. Diagnostic delays due to lack of access to a specialist and costly therapies are still a major obstacle for many patients. Even in first-world countries, the treat-to-target principle and the goal of disease remission are often missed. Thus, rheumatoid arthritis (RA) is still the reason for disability and reduced quality of life for many patients. So, is it time to move the goalpost even further? Where are we heading next? And will we finally be able to cure the disease? These questions are addressed in our review article.
U2 - 10.1177/1759720X221076211
DO - 10.1177/1759720X221076211
M3 - SCORING: Review article
C2 - 35154419
VL - 14
SP - 1759720X221076211
JO - THER ADV MUSCULOSKEL
JF - THER ADV MUSCULOSKEL
SN - 1759-720X
ER -
